Revance

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.30-$7.56
Market Cap
$381M
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$256.9M
Revenue Growth (YoY)
10.7%
Gross Profit (12 Mos)
$103.6M
Diluted EPS
-$3.34

News

See more

Yahoo Finance • yesterday

Investors who lost money on Revance Therapeutics, Inc.(RVNC) should contact Levi & Korsinsky about pending Class Action - RVNC

Yahoo Finance • 2 days ago

RVNC INVESTOR ALERT: Kirby McInerney LLP Reminds Revance Therapeutics, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

Yahoo Finance • 2 days ago

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Shareholders

Yahoo Finance • 3 days ago

DEADLINE ALERT for RVNC, REGN, and BIOA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

About

CEO
Mr. Mark J. Foley
CFO
Mr. Tobin C. Schilke
Address
1222 Demonbreun Street, Nashville, TN, United States, 37203
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
597